Oriental Aromat. (OAL)

FairStock Score: 21/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding is high at 74.17%, aligning management with minority shareholders.
• Sales grew 13.03%, showing the business still has customer demand and topline traction.
• Book value of ₹196.44 provides some asset support, with P/B at 1.57 rather than an extreme premium.
• Debt/equity of 0.60 is moderate and does not appear dangerously leveraged.

Concerns

• P/E of 1000 and PEG of 76.75 indicate earnings have collapsed, leaving no earnings yield.
• ROE of 3.67% and ROCE of 7.89% show poor returns on capital and weak value creation.
• Latest quarter posted a net loss of ₹2 Cr despite ₹252 Cr of sales, revealing fragile margins.
• Piotroski F-Score of 4/9 and profit growth of -126.89% point to fundamental deterioration.

AI Analysis

Oriental Aromat is exactly the kind of name that forces me to slow down. I don't ask whether it is a good company; I ask whether it is a good business at a sensible price. The numbers tell me this is not a compounding machine today. A trailing P/E of 1000 is not a valuation; it is an absence of earnings. Growth of 13% in sales means nothing if profits fall 126.89% and the latest quarter still shows a ₹2 Cr loss on ₹252 Cr of sales. Graham would call this speculation, not investment. The balance sheet is not terrible—book value is ₹196.44 and debt-to-equity is 0.60—but paying ₹308.36, or 1.57 times book, for a 3.67% ROE is the opposite of margin of safety. ROCE of 7.89% barely covers the cost of capital, so every rupee retained is likely earning less than an average shareholder could earn elsewhere. The F-score of 4/9 and FairStock score of 14/100 tell me the fundamentals are deteriorating, not improving. Yes, promoter holding at 74.17% is comforting—they are in the boat with you—and top-line growth shows the company has customers. But earning power is what determines intrinsic value. Without profit, there is no owner earnings. I would need proof that margins can be rebuilt and the business can earn a decent return on capital before I would think about buying. Until then, the price is low only compared to a speculative past. This looks like a turnaround situation, but it is not a justified bet yet.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer